Header Logo

Connection

Lela Buckingham to Biomarkers, Tumor

This is a "connection" page, showing publications Lela Buckingham has written about Biomarkers, Tumor.
Connection Strength

0.244
  1. Use of cervical mucus to screen for gynecological malignancies: a pilot study. Mod Pathol. 2013 Nov; 26(11):1508-13.
    View in: PubMed
    Score: 0.094
  2. The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol. 2007 May; 2(5):414-22.
    View in: PubMed
    Score: 0.061
  3. Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal Cancer. Am J Clin Pathol. 2020 07 07; 154(2):266-276.
    View in: PubMed
    Score: 0.038
  4. Ectopic Thyroid Tissue: Immunohistochemistry and Molecular Analysis. Appl Immunohistochem Mol Morphol. 2018 Nov/Dec; 26(10):734-739.
    View in: PubMed
    Score: 0.034
  5. The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib. Clin Cancer Res. 2008 Apr 01; 14(7):2088-94.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.